Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

Improving clinical outcomes among high risk Class III β thalassemia major patients (Class IIIHR) receiving an allogeneic SCT remains a challenge. From October, 2009 a treosulfan based regimen (TreoFluT) was used for all consecutive Class III patients (n = 50). The clinical outcomes were compared wit...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mathews, Vikram, George, Biju, Viswabandya, Auro, Abraham, Aby, Ahmed, Rayaz, Ganapule, Abhijeet, Sindhuvi, Eunice, Lakshmi, Kavitha M., Srivastava, Alok
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637210/
https://ncbi.nlm.nih.gov/pubmed/23637873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061637
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires